GLP1R and cancer: Fig. 3 presented the risk of malignant neoplasms between GLP-1 RA and non-GLP-1 RA groups, demonstrating a hazard ratio (HR) of 0.93 (95% CI: 0.90–0.96), which indicates a statistically significant reduction in the overall risk of cancer.